文献速递运动医学关节外科

损伤至手术间隔对人前交叉韧带来源细胞愈合潜能的影响

Influence of the Injury-to-Surgery Interval on the Healing Potential of Human Anterior Cruciate Ligament-Derived Cells.
PubMed 文献 · Am J Sports Med · 2017-03-10

研究将人前交叉韧带断裂组织按损伤至手术间隔分为早期组(≤3个月)和慢性组(>3个月),提取细胞用于免疫缺陷大鼠前交叉韧带重建模型。早期组细胞在组织学、影像学和生物力学上均显示更强的腱骨愈合潜能。作者认为早期移植前交叉韧带残端组织可能加速并增强腱骨愈合。

要点

  • 早期组(≤3个月)细胞的组织学评估显示早期愈合、诱导软骨内成骨样整合及成熟骨长入。
  • 微计算机断层扫描显示早期组第4周和第8周胫骨骨隧道较慢性组和PBS组显著缩小(P<.05)。
  • 早期组生物力学抗张强度显著大于其他组(P<.05)。

核心结论

  • 在免疫缺陷大鼠前交叉韧带重建模型中,与慢性期获取的人前交叉韧带来源细胞相比,损伤后早期获取的细胞具有更强的腱骨愈合潜能。

研究设计与样本

  • 受控实验室研究;从接受关节镜初次前交叉韧带重建的患者获取成人人前交叉韧带断裂组织,按损伤至手术间隔分为早期组(≤3个月)和慢性组(>3个月)。
  • 76只10周龄雌性免疫缺陷大鼠接受前交叉韧带重建,并关节腔内给予早期组来源细胞(n=5)、慢性组来源细胞(n=5)或仅磷酸盐缓冲液(n=5)。
  • 术后8周内进行组织学(第2、4、8周)、免疫组化(第2周)、影像学(第0、2、4、8周)和生物力学(第8周)分析以评估腱骨愈合。

主要发现

  • 早期组组织学评估显示早期愈合、诱导软骨内成骨样整合及成熟骨长入。
  • 微计算机断层扫描显示早期组第4周和第8周胫骨骨隧道较慢性组和PBS组显著缩小(P<.05)。
  • 早期组生物力学抗张强度显著大于其他组(P<.05)。
  • 早期组内在血管生成/成骨及人源血管生成/成骨增强进一步证明其加速的愈合潜能。

临床怎么用

  • 作者认为,在前交叉韧带重建手术中,损伤后早期移植前交叉韧带残端组织可能加速并增强腱骨愈合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vascular CD34+ cells in anterior cruciate ligament (ACL) tissue have the potential for high proliferation and multilineage differentiation that can accelerate tendon-bone healing. While patient characteristics, such as age, can affect tendon-bone healing, the influence of elapsed time after injury on the healing process is unclear. HYPOTHESIS: Cells obtained during the early phase after injury will exhibit a greater tendon-bone healing potential compared with chronic phase counterparts when applied to an immunodeficient rat model of ACL reconstruction. STUDY DESIGN: Controlled laboratory study. METHODS: Adult human ACL-ruptured tissue was harvested from patients undergoing arthroscopic primary ACL reconstruction and classified into 2 groups based on the time elapsed between injury and surgery: (1) early group (≤3 months from injury) and (2) chronic group (>3 months from injury). In addition, 76 ten-week-old female immunodeficient rats underwent ACL reconstruction, followed by intracapsular administration of one of the following: (1) ACL-derived cells from the early group (n = 5), (2) ACL-derived cells from the chronic group (n = 5), or (3) phosphate-buffered saline (PBS) only (n = 5). During the 8 weeks after surgery, histological (weeks 2, 4, 8), immunohistochemical (week 2), radiographic (weeks 0, 2, 4, 8), and biomechanical (week 8) analyses were performed to evaluate tendon-bone healing. RESULTS: In the early group, the histological evaluation showed early healing, induction of endochondral ossification-like integration, and mature bone ingrowth. Micro-computed tomography showed that the tibial bone tunnels at week 4 and week 8 were significantly reduced in the early group compared with those in the chronic group and PBS group ( P < .05). Moreover, biomechanical tensile strength was significantly greater in the early group than in the other groups ( P < .05). An accelerated healing potential in the early group was further demonstrated by the enhancement of intrinsic angiogenesis/osteogenesis and human-derived vasculogenesis/osteogenesis. CONCLUSION: Compared with human ACL-derived cells obtained during the chronic phase, cells obtained during the early phase after injury have a greater tendon-bone healing potential when used in an immunodeficient rat model of ACL reconstruction. CLINICAL RELEVANCE: During ACL reconstruction surgery, transplanting ACL remnant tissue in the early phase after injury could accelerate and enhance tendon-bone healing.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Inokuchi T, Matsumoto T, Takayama K, et al. Influence of the Injury-to-Surgery Interval on the Healing Potential of Human Anterior Cruciate Ligament-Derived Cells. Am J Sports Med. 2017. PMID: 28282242. doi:10.1177/0363546517689871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。